He N - Search Results

1

Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.

Shi J, Yao D, Liu W, Wang N, Lv H, Zhang G, Ji M, Xu L, He N, Shi B, Hou P. Shi J, et al. Among authors: he n. BMC Cancer. 2012 Feb 1;12:50. doi: 10.1186/1471-2407-12-50. BMC Cancer. 2012. PMID: 22292935 Free PMC article.

2

Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer.

Yao D, Shi J, Shi B, Wang N, Liu W, Zhang G, Ji M, Xu L, He N, Hou P. Yao D, et al. Among authors: he n. Clin Chim Acta. 2012 Apr 11;413(7-8):787-94. doi: 10.1016/j.cca.2012.01.013. Epub 2012 Jan 21. Clin Chim Acta. 2012. PMID: 22285775

3

Frequent gene amplification predicts poor prognosis in gastric cancer.

Shi J, Yao D, Liu W, Wang N, Lv H, He N, Shi B, Hou P, Ji M. Shi J, et al. Among authors: he n. Int J Mol Sci. 2012;13(4):4714-4726. doi: 10.3390/ijms13044714. Epub 2012 Apr 13. Int J Mol Sci. 2012. PMID: 22606006 Free PMC article.

4

Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.

Yang Q, Wu K, Ji M, Jin W, He N, Shi B, Hou P. Yang Q, et al. Among authors: he n. J Biomed Nanotechnol. 2013 Sep;9(9):1607-16. doi: 10.1166/jbn.2013.1713. J Biomed Nanotechnol. 2013. PMID: 23980508

5

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.

Fu J, Lv H, Guan H, Ma X, Ji M, He N, Shi B, Hou P. Fu J, et al. Among authors: he n. BMC Cancer. 2013 Oct 8;13:462. doi: 10.1186/1471-2407-13-462. BMC Cancer. 2013. PMID: 24098937 Free PMC article.

6

Prognostic significance of aberrant gene methylation in gastric cancer.

Shi J, Zhang G, Yao D, Liu W, Wang N, Ji M, He N, Shi B, Hou P. Shi J, et al. Among authors: he n. Am J Cancer Res. 2012;2(1):116-29. Epub 2011 Nov 21. Am J Cancer Res. 2012. PMID: 22206050 Free PMC article.

7

CYP2S1 is a synthetic lethal target in BRAF^V600E-driven thyroid cancers.

Li Y, Su X, Feng C, Liu S, Guan H, Sun Y, He N, Ji M, Hou P. Li Y, et al. Among authors: he n. Signal Transduct Target Ther. 2020 Sep 11;5(1):191. doi: 10.1038/s41392-020-00231-6. Signal Transduct Target Ther. 2020. PMID: 32913191 Free PMC article.

8

Detection of p16 hypermethylation in gastric carcinomas using a seminested methylation-specific PCR.

Hou P, Ji MJ, Shen JY, He NY, Lu ZH. Hou P, et al. Biochem Genet. 2005 Feb;43(1-2):1-9. doi: 10.1007/s10528-005-1062-8. Biochem Genet. 2005. PMID: 15859515

9

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAF^V600E-driven human cancers.

Wu Y, Shi L, Zhao Y, Chen P, Cui R, Ji M, He N, Wang M, Li G, Hou P. Wu Y, et al. Among authors: he n. NPJ Precis Oncol. 2021 Jan 22;5(1):3. doi: 10.1038/s41698-020-00140-5. NPJ Precis Oncol. 2021. PMID: 33483600 Free PMC article.

10

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells.

Da C, Pu J, Liu Z, Wei J, Qu Y, Wu Y, Shi B, Yang J, He N, Hou P. Da C, et al. Among authors: he n. Signal Transduct Target Ther. 2021 Nov 24;6(1):399. doi: 10.1038/s41392-021-00793-z. Signal Transduct Target Ther. 2021. PMID: 34815381 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,562 results

Search Page

Filters